trademarkia
...
...
NATIVE GENE THERAPY

NATIVE GENE THERAPY Trademark Information

Trademark by OMEGA THERAPEUTICS, INC.

Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NATIVE GENE THERAPY
Status/Status Date:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
4/17/2022
Estimated Response Deadline: 10/17/2022
Serial Number: 97079718
Filing Date: 10/18/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
OMEGA THERAPEUTICS, INC.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("GENE THERAPY")
Correspondent:
********
********
***** ****
Current Status:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
4/17/2022
Correspondent Search:
CHRISTINA M. LICURSI is a correspondent of NATIVE GENE THERAPY trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on